Navigation Links
Drug 'shield' helps target antibiotic resistant bacteria
Date:7/7/2011

A new technique which targets antibiotic-resistant bacteria and shields patients from the toxic parts of an antibiotic drug has been developed by Cardiff University scientists.

Dr Elaine Ferguson from Cardiff University's School of Dentistry has utilised a new technique which attaches tiny nano-sized biodegradable polymers to the antibiotic drug - colistin.

Use of the drug colistin to fight infection has been limited as it is known to be toxic to the kidneys and nerves despite the fact that it has been found to be effective against new multi-drug resistant bacteria, like NDM-1.

Cardiff University scientists believe the new technique will help under-used antibiotic drugs like colistin to be used to fight against the spread of life-threatening bacterial infections.

"The technology we've developed came as a direct response to an urgent medical need for better antibiotics to safely treat patients with life threatening infections. Very few new antimicrobial drugs have emerged despite intensive research, with only two new classes of antibiotics developed in the last 30 years," according to Dr Ferguson who worked alongside Cardiff University's Professor David Thomas and Professor Timothy Walsh to develop the technique.

"Our new approach allows existing effective therapies to be improved to help patients with severe infections who may otherwise suffer significant side effects after treatment.

"The polymer shields the drug molecule making it less toxic to the body while, at sites of infection, there is an enzyme present which removes the polymer- specifically activating the drug where it is needed" she added.

The research was supported by The Severnside Alliance for Translational Research (SARTRE) - a major collaboration between Cardiff and Bristol Universities designed to translate medical research to improve lives.

The seedcorn funding for the research from SARTRE, through the Medical Research Council's Developmental Pathway Funding Scheme, helped the project progress quickly to the stage where additional grant funding has been secured.

Ernest Azzopardi, a plastic surgeon studying for his PhD with the group, has also been awarded a Welsh Clinical Academic Training Fellowship and a grant from the EU European Social Fund to continue the work initiated with the seedcorn funding. The team includes materials scientists Dr Peter Griffiths from Cardiff University's School of Chemistry and Professor Terence Cosgrove from the University of Bristol, who have recently secured funding with Dr Ferguson to undertake neutron scattering at the Institut Laue-Langevin (ILL) in Grenoble (France).

Professor David Thomas, who worked alongside Dr Ferguson on developing the new technique, added: "The interdisciplinary nature of our work in drug delivery allows the possibility of developing truly innovative approaches to the management of human disease".


'/>"/>

Contact: Dr Corinne Squire
029-207-44190
Cardiff University
Source:Eurekalert

Related biology news :

1. Shielding body protects brain from shell shocking blast injuries
2. U Alberta find could shield humans from influenza virus
3. Orbel Introduces the Board Shielding Wizard
4. Bacteria launch a shield to resist attack
5. Lotus-plant-inspired dust-busting shield to protect space gear
6. Life Sciences Discovery Fund helps launch 3 programs to advance health research and development
7. Landsat 5 satellite helps emergency managers fight largest fire in Arizona history
8. Hormone test helps predict success in IVF
9. USC: Active social, spiritual and physical life helps prevent health decline in seniors
10. Reforestation research in Latin America helps build better forests
11. Social network helps in discovery of a species of plant lice for the first time in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... 2017 Report Highlights ... The global synthetic-biology market reached nearly ... 2021, growing at a compound annual growth rate (CAGR) of ... the global markets for synthetic biology. - Analyses of global ... projections of compound annual growth rates (CAGRs) through 2021. - ...
(Date:2/7/2017)... 2017   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that the latest ... highly flexible and award winning eClinical solution, is now ... is a proven Software-as-a-Service (SaaS) clinical research technology ... but also delivers an entire suite of eClinical tools ...
(Date:2/6/2017)... 6, 2017 According to Acuity Market ... border authorities to continue to embrace biometric and ... 2143 Automated Border Control (ABC) eGates and 1436 ... more than 163 ports of entry across the ... achieving a combined CAGR of 37%. APC Kiosks ...
Breaking Biology News(10 mins):
(Date:2/18/2017)... Kurzlehrgang mit Fokus auf Assay zum ... metaproteomische Analyse des Darm-Mikrobioms bei Säuglingen dar   ... Wie ... Peretz , Scientific Director bei ImmuneCarta, einen Kurzlehrgang zu ... intrazellulärer Zytokine bei adoptiven Zelltherapie-Studien im Rahmen der jährlich ...
(Date:2/17/2017)... , Feb. 17, 2017  BioGenex, a ... announce development of a novel system for quantitative ... with the University of Rochester (NY, USA) and ... The new system is able to accurately quantify ... HER2 (Human epidermal growth factor receptor-2) in clinical ...
(Date:2/16/2017)... ... ... Avomeen & MichBio will be hosting a BioMixer next week Thursday, February ... (4840 Venture Dr., Ann Arbor, Michigan 48108). BioMixers are a casual, members-only networking ... peers, make new connections and talk bio biz. , Cost:, ...
(Date:2/16/2017)... , Feb. 16, 2017 ... "Synthetic Biology: Global Markets" report to their ... ... products (synthetic genes, biobrick parts, delivery plasmids, chassis organisms, ... synthesis and assembly, genome editing, bioinformatics and specialty media) ...
Breaking Biology Technology: